Limiting prescriber autonomy may reduce drug-related adverse events

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.293, 2000-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Detection of drug-related adverse events in hospitals

By Thürmann Petra A  

Expert Opinion on Drug Safety, Vol. 2, Iss. 5, 2003-09 ,pp. : 447-449

Informa Healthcare

Access to resources Recommend Favorite

Counting the Costs of Drug-Related Adverse Events

By White T.J.  

PharmacoEconomics, Vol. 15, Iss. 5, 1999-05 ,pp. : 445-458

Adis International

Access to resources Recommend Favorite

Adverse drug events in outpatients

By  

Inpharma, Vol. 1, Iss. 1385, 2003-01 ,pp. : 29-29

Adis International

Access to resources Recommend Favorite

Preventability of Drug-Related Harms - Part II: Proposed Criteria, Based on Frameworks that Classify Adverse Drug Reactions

By Aronson Jeffrey K.   Ferner Robin E.  

Drug Safety, Vol. 33, Iss. 11, 2010-11 ,pp. : 995-1002

Adis International

Access to resources Recommend Favorite

Metabolic bioactivation and drug-related adverse effects: current status and future directions from a pharmaceutical research perspective

By Tang Wei   Lu Anthony Y.H.  

Drug Metabolism Reviews, Vol. 42, Iss. 2, 2010-05 ,pp. : 225-249

Informa Healthcare

Access to resources Recommend Favorite